 |
|
Means to an End, Not the End
Susan Nedorost, MD;
Matthew Zirwas, MD
Arch Dermatol. 2008;144(6):788-790.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Technology has rapidly changed our capabilities in many fields, including medicine. Two of the most important developments have been immediate, on-demand, on-site access to information via the Internet and the ability to easily collect, organize, and analyze huge volumes of information with easy-to-use computerized databases. Our challenge is to best use our new access to information.
In this issue of the Archives, the North American Contact Dermatitis Group has shared a detailed accounting of patch test results in a large number of patients with anogenital dermatitis.1 This sort of epidemiologic data is useful in determining which standard antigens are most and least useful for patch testing in patients with dermatitis in a specific distribution. Data housed in a database such as the multicenter collaboration used for this article are useful to researchers. Many tertiary contact dermatitis centers maintain a similar database that registers . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLE
Anogenital Dermatitis in Patients Referred for Patch Testing: Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 1994-2004
Erin M. Warshaw, Laura M. Furda, Howard I. Maibach, Robert L. Rietschel, Joseph F. Fowler, Jr, Donald V. Belsito, Kathryn A. Zug, Vincent A. DeLeo, James G. Marks, Jr, C. G. Toby Mathias, Melanie D. Pratt, Denis Sasseville, Frances J. Storrs, and James S. Taylor
Arch Dermatol. 2008;144(6):749-755.
ABSTRACT
| FULL TEXT
|
